IB Acquisition Corp. (IBAC) stock
IBACNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBACR
$10.85+0.00 (0.00%)
Close on Nov 18, 2026Market cap $54.34MP/E –Yield –
IB Acquisition operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
IB Acquisition's operating income for the twelve months ending Jun 30, 2026 was -$1.79M. For fiscal 2025 it was -$748.91K.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$748.91K | – |
| FY2024 | Sep 30, 2024 | -$523.97K | – |
| FY2023 | Sep 30, 2023 | -$6.84K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$624.43K | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$748.18K | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$180.00K | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$236.77K | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$172.21K | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$163.49K | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$176.44K | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$165.46K | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$76.38K | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$194.65K | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$87.49K | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$6.70K | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$48 | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$48 | – |
See a number that looks wrong?